Brokerages Set Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Target Price at $18.22
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target […]
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten research firms that are covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target […]
